(Q39547783)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21544629%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

title

Sorafenib augments cytotoxic effect of S-1 in vitro and in vivo through TS suppression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21544629%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

0 references

Katsunori Tatsugami

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21544629%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Akira Yokomizo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21544629%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Masatoshi Eto

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21544629%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Junichi Inokuchi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21544629%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Kentaro Kuroiwa

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21544629%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Keijiro Kiyoshima

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21544629%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Seiji Naito

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21544629%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

5 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21544629%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

30 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21544629%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21544629%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21544629%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

1557-1564

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21544629%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00280-011-1660-6

30 January 2020

exact match

0 references

cites work

The von Hippel-Lindau tumor suppressor gene and kidney cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1660-6

Sorafenib in advanced clear-cell renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1660-6

Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1660-6

Phase II study of oral S-1 for treatment of metastatic colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1660-6

Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1660-6

S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1660-6

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1660-6

Addition of S-1 to the epidermal growth factor receptor inhibitor gefitinib overcomes gefitinib resistance in non-small cell lung cancer cell lines with MET amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1660-6

Synergistic antitumor effect of S-1 and the epidermal growth factor receptor inhibitor gefitinib in non-small cell lung cancer cell lines: role of gefitinib-induced down-regulation of thymidylate synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1660-6

Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1660-6

Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1660-6

Identification of a thymidylate synthase ribonucleoprotein complex in human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1660-6

The E2F transcription factor is a cellular target for the RB protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1660-6

Specificity in the activation and control of transcription factor E2F-dependent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1660-6

Regulation of TopBP1 oligomerization by Akt/PKB for cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1660-6

Kinase inhibition with BAY 43-9006 in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1660-6

10.1007/S00280-011-1660-6

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21544629%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference